Advertisement

Topics

Risk for Dysplastic or Neoplastic Progression of Irregular Z Line

12:43 EDT 14 Mar 2018 | NEJM

Prospectively collected data support current guideline recommendations to forego biopsy in patients with an irregular Z line.

Original Article: Risk for Dysplastic or Neoplastic Progression of Irregular Z Line

NEXT ARTICLE

More From BioPortfolio on "Risk for Dysplastic or Neoplastic Progression of Irregular Z Line"

Advertisement
Quick Search
Advertisement
Advertisement